V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013023 | 270016696 | 1.88 | 63 | Adjuvant (A) | 2017-05-18 | 2017-05-18 | COPP + Dacarbazine | N | null | 270013279 | COPP + DACARBAZINE |
| 270013024 | 270008569 | 0 | 57.6 | Curative (C) | 2018-02-26 | 2018-03-23 | Trial Unspecified | Y | N | 270013285 | TRIAL |
| 270013026 | 270008571 | null | 88 | Curative (C) | 2019-07-18 | 2019-08-14 | Cetuximab 14 day | N | N | 270013292 | CETUXIMAB |
| 270013027 | 270008572 | null | 61.1 | null | 2013-06-05 | 2013-08-11 | BEACOPP | N | N | 270013299 | BEACOPP |
| 270013028 | 270014052 | 1.5 | 62 | Adjuvant (A) | 2013-08-31 | 2013-10-07 | CETUXIMAB | N | N | 270013302 | CETUXIMAB |
| 270013029 | 270014052 | 1.32 | 58.55 | Adjuvant (A) | 2014-05-07 | 2014-05-10 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013302 | TRIAL |
| 270013030 | 270014052 | null | 98 | Curative (C) | 2015-08-10 | 2015-10-07 | CETUXIMAB | 2 | null | 270013302 | CETUXIMAB |
| 270013031 | 270008573 | 1.75 | null | Curative (C) | 2017-04-11 | 2018-04-07 | CETUXIMAB | N | N | 270013315 | CETUXIMAB |
| 270013032 | 270008574 | 1.67 | 65 | Curative (C) | 2016-09-13 | 2016-11-02 | Cetuximab 7 day (>Cycle 2) | N | null | 270013318 | CETUXIMAB |
| 270013033 | 270008575 | 1.76 | 80.3 | Curative (C) | 2016-05-16 | 2016-05-25 | COPP + Dacarbazine | N | N | 270013318 | COPP + DACARBAZINE |
| 270013034 | 270018226 | 1.43 | 105.1 | Curative (C) | 2017-03-02 | 2017-04-11 | HD EuroNet-PHL-C1 COPDAC | N | Y | 270013327 | TRIAL |
| 270013035 | 270008576 | 0 | 71 | Curative (C) | 2013-09-13 | 2013-09-13 | HD EuroNet-PHL-C1 Relapsed IEP | null | null | 270013336 | TRIAL |
| 270013036 | 270008577 | 0 | 77.25 | null | 2016-03-30 | 2016-06-09 | COPP + Dacarbazine | N | null | 270013336 | COPP + DACARBAZINE |
| 270013037 | 270008578 | 0 | null | Curative (C) | 2016-08-17 | 2016-08-17 | COPP + Dacarbazine | null | N | 270013349 | COPP + DACARBAZINE |
| 270013038 | 270008581 | 0 | 85 | Curative (C) | 2013-07-28 | 2013-09-23 | COPP + Dacarbazine | N | N | 270013353 | COPP + DACARBAZINE |
| 270013039 | 270014056 | 2 | 47.2 | Curative (C) | 2016-05-08 | 2016-07-28 | BEACOPP-14 | Y | N | 270013353 | BEACOPP |
| 270013040 | 270008583 | null | 90.4 | Curative (C) | 2017-12-14 | 2018-02-05 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013361 | TRIAL |
| 270013041 | 270008584 | 1.62 | 36.3 | Curative (C) | 2014-06-20 | 2014-06-20 | Cetuximab 7 day (Cycle 1) | 99 | N | 270013366 | CETUXIMAB |
| 270013042 | 270008585 | 1.72 | 40.6 | Curative (C) | 2016-10-03 | 2017-10-11 | CETUXIMAB | 2 | N | 270013366 | CETUXIMAB |
| 270013043 | 270008587 | null | 103.4 | Curative (C) | 2014-02-08 | 2014-03-09 | Trial Unspecified | N | N | 270013367 | TRIAL |
| 270013044 | 270008588 | 1.66 | 80 | Palliative (P) | 2015-01-25 | 2015-05-10 | CETUXIMAB | 02 | null | 270013382 | CETUXIMAB |
| 270013045 | 270008589 | 1.8 | 98.5 | Palliative (P) | 2015-08-19 | 2016-02-02 | CETUXIMAB | N | Y | 270013382 | CETUXIMAB |
| 270013046 | 270008591 | 1.9 | 31.2 | Curative (C) | 2016-03-20 | 2016-03-20 | CETUXIMAB | 2 | N | 270013386 | CETUXIMAB |
| 270013047 | 270014062 | 1.66 | 78.8 | Palliative (P) | 2014-04-10 | 2014-10-20 | CETUXIMAB | 02 | N | 270013387 | CETUXIMAB |
| 270013048 | 270008594 | 0 | 45.2 | Curative (C) | 2013-08-01 | 2013-08-08 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013395 | TRIAL |
| 270013049 | 270008595 | 1.8 | 73.3 | Curative (C) | null | 2015-07-04 | Escalated BEACOPP | N | N | 270013398 | BEACOPP |
| 270013050 | 270008596 | 0 | 72.6 | Curative (C) | 2016-03-19 | 2016-07-09 | COPP + Dacarbazine | null | N | 270013401 | COPP + DACARBAZINE |
| 270013051 | 270008597 | 1.85 | null | Curative (C) | 2016-05-15 | 2016-07-31 | BEACOPP-14 | N | N | 270013405 | BEACOPP |
| 270013052 | 270014063 | 1.56 | 19.5 | Curative (C) | 2017-09-12 | 2017-09-17 | COPP + Dacarbazine | N | N | 270013410 | COPP + DACARBAZINE |
| 270013053 | 270014063 | 0 | 65.45 | Palliative (P) | 2017-10-01 | 2017-10-02 | Trial Unspecified | N | N | 270013410 | TRIAL |
| 270013054 | 270014063 | 1.7 | 87.3 | Curative (C) | 2018-02-28 | 2018-02-28 | HD EuroNet-PHL-C1 COPDAC | 1 | N | 270013410 | TRIAL |
| 270013055 | 270014063 | 1.45 | 41.7 | Curative (C) | null | 2016-11-06 | COPP + Dacarbazine | N | N | 270013410 | COPP + DACARBAZINE |
| 270013056 | 270014063 | 1.68 | 60 | Palliative (P) | 2016-05-23 | 2016-07-20 | CETUXIMAB | N | N | 270013410 | CETUXIMAB |
| 270013057 | 270008601 | 1.65 | 78 | Curative (C) | 2016-01-25 | 2016-05-09 | BEACOPP-14 | 2 | N | 270013452 | BEACOPP |
| 270013058 | 270008602 | 1.72 | 99.7 | Palliative (P) | 2016-05-28 | 2016-05-28 | Cetuximab 14 day | N | N | 270013457 | CETUXIMAB |
| 270013059 | 270008603 | 0 | 59.6 | Curative (C) | 2013-05-27 | 2013-07-16 | Cetuximab 14 day | N | N | 270013459 | CETUXIMAB |
| 270013060 | 270008605 | 1.85 | 76.2 | Palliative (P) | 2013-09-09 | 2013-11-08 | Trial Unspecified | 01 | N | 270013461 | TRIAL |
| 270013061 | 270008606 | 1.52 | 59 | Curative (C) | 2017-10-15 | 2017-10-30 | Cetuximab 14 day | N | Y | 270013464 | CETUXIMAB |
| 270013062 | 270016704 | 1.8 | 51 | Curative (C) | 2017-09-18 | 2017-10-09 | BEACOPP-14 | 1 | N | 270013475 | BEACOPP |
| 270013063 | 270008608 | 1.77 | 80.5 | Curative (C) | 2018-02-26 | 2018-03-01 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013478 | TRIAL |
| 270013064 | 270008610 | null | 42.2 | Adjuvant (A) | null | 2014-12-31 | COPP + Dacarbazine | null | null | 270013478 | COPP + DACARBAZINE |
| 270013065 | 270008611 | 1.25 | 41.7 | Adjuvant (A) | 2016-01-14 | 2016-03-21 | COPP + Dacarbazine | 02 | N | 270013483 | COPP + DACARBAZINE |
| 270013066 | 270014068 | 1.68 | 60 | Curative (C) | 2014-03-09 | 2014-03-13 | Trial Unspecified | 2 | N | 270013488 | TRIAL |
| 270013067 | 270008614 | 0 | 99.4 | Curative (C) | 2017-02-28 | 2017-02-28 | COPP + Dacarbazine | N | null | 270013497 | COPP + DACARBAZINE |
| 270013068 | 270008614 | null | 83 | Curative (C) | null | 2014-05-16 | BEACOPP-14 | N | N | 270013497 | BEACOPP |
| 270013069 | 270008614 | null | 50 | Curative (C) | 2013-07-07 | 2013-07-07 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270013497 | CETUXIMAB |
| 270013070 | 270008617 | null | 31.2 | Curative (C) | 2014-03-31 | 2014-03-31 | COPP + Dacarbazine | N | N | 270013509 | COPP + DACARBAZINE |
| 270013071 | 270008621 | 1.82 | 60 | Curative (C) | 2014-04-23 | 2014-04-23 | Escalated BEACOPP | N | N | 270013510 | BEACOPP |
| 270013072 | 270008624 | null | 51 | Curative (C) | 2017-07-19 | 2017-09-25 | Trial Unspecified | Y | N | 270013518 | TRIAL |
| 270013073 | 270008625 | 1.63 | 45.2 | Curative (C) | 2017-02-25 | 2017-05-05 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013521 | TRIAL |